Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Advances in microfluidic PCR for point-of-care infectious disease diagnostics BIOTECHNOLOGY ADVANCES Park, S., Zhang, Y., Lin, S., Wang, T., Yang, S. 2011; 29 (6): 830-839

Abstract

Global burdens from existing or emerging infectious diseases emphasize the need for point-of-care (POC) diagnostics to enhance timely recognition and intervention. Molecular approaches based on PCR methods have made significant inroads by improving detection time and accuracy but are still largely hampered by resource-intensive processing in centralized laboratories, thereby precluding their routine bedside- or field-use. Microfluidic technologies have enabled miniaturization of PCR processes onto a chip device with potential benefits including speed, cost, portability, throughput, and automation. In this review, we provide an overview of recent advances in microfluidic PCR technologies and discuss practical issues and perspectives related to implementing them into infectious disease diagnostics.

View details for DOI 10.1016/j.biotechadv.2011.06.017

View details for Web of Science ID 000296821900024

View details for PubMedID 21741465

View details for PubMedCentralID PMC3186827